A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors
International Journal of Molecular Sciences · 2023
DOI: 10.3390/ijms241411515 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Thayne Woycinck Kowalski und 9 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Genetics and Molecular Biology, Genetics Department, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, B…. Hauptthemen laut MEDLINE: Thalidomide, Multiple Myeloma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Council for Scientific and Technological Development, Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul, Hospital de Clínicas de Porto Alegre.
Abstract (Originalsprache)
Several molecular mechanisms of thalidomide embryopathy (TE) have been investigated, from anti-angiogenesis to oxidative stress to cereblon binding. Recently, it was discovered that thalidomide and its analogs, named immunomodulatory drugs (IMiDs), induced the degradation of C2H2 transcription factors (TFs). This mechanism might impact the strict transcriptional regulation of the developing embryo. Hence, this study aims to evaluate the TFs altered by IMiDs, prioritizing the ones associated with embryogenesis through transcriptome and systems biology-allied analyses. This study comprises only the experimental data accessed through bioinformatics databases. First, proteins and genes reported in the literature as altered/affected by the IMiDs were annotated. A protein systems biology network was evaluated. TFs beta-catenin (CTNNB1) and SP1 play more central roles: beta-catenin is an essential protein in the network, while SP1 is a putative C2H2 candidate for IMiD-induced degradation. Separately, the differential expressions of the annotated genes were analyzed through 23 publicly available transcriptomes, presenting 8624 differentially expressed genes (2947 in two or more datasets). Seventeen C2H2 TFs were identified as related to embryonic development but not studied for IMiD exposure; these TFs are potential IMiDs degradation neosubstrates. This is the first study to suggest an integration of IMiD molecular mechanisms through C2H2 TF degradation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Program in Genetics and Molecular Biology, Genetics Department, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 91501-970, Brazil.
- Teratogen Information System (SIAT), Medical Genetics Service, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre 90035-903, Brazil.
- Laboratory of Genomic Medicine, Center of Experimental Research, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre 90035-903, Brazil.
- Bioinformatics Core, Hospital de Clínicas de Porto Alegre (HCPA), Porto Alegre 90035-903, Brazil.
- Biomedical Sciences Course, Centro Universitário CESUCA, Cachoeirinha 94935-630, Brazil.
- Post-Graduation Program in Medicine, Medical Sciences, Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre 90035-003, Brazil.
ORCID-Profile: Thayne Woycinck Kowalski, Mariléa Furtado Feira, Vinícius Oliveira Lord, Giovanna Câmara Giudicelli, Mariana Recamonde-Mendoza
Förderung
- National Council for Scientific and Technological Development
- Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul
- Hospital de Clínicas de Porto Alegre
- Fundação de Amparo à Pesquisa do Rio Grande do Sul (FAPERGS)
- Hospital de Clínicas de Porto Alegre (HCPA)-Fundo de Incentivo à Pesquisa e Eventos (FIPE)
- CNPq scholarship
- HCPA scholarship
Zitieren
APA
Kowalski, T. W., Feira, M. F., Lord, V. O., Gomes, J. D. A., Giudicelli, G. C., Fraga, L. R., Sanseverino, M. T. V., Recamonde-Mendoza, M., Schuler-Faccini, L., & Vianna, F. S. L. (2023). A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411515
Vancouver
Kowalski TW, Feira MF, Lord VO, Gomes JDA, Giudicelli GC, Fraga LR, et al. A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411515
BibTeX
@article{Kowalski2023,
author = {Kowalski, Thayne Woycinck and Feira, Mariléa Furtado and Lord, Vinícius Oliveira and Gomes, Julia do Amaral and Giudicelli, Giovanna Câmara and Fraga, Lucas Rosa and Sanseverino, Maria Teresa Vieira and Recamonde-Mendoza, Mariana and Schuler-Faccini, Lavinia and Vianna, Fernanda Sales Luiz},
title = {A New Strategy for the Old Challenge of Thalidomide: Systems Biology Prioritization of Potential Immunomodulatory Drug (IMiD)-Targeted Transcription Factors},
journal = {International Journal of Molecular Sciences},
year = {2023},
doi = {10.3390/ijms241411515}
}
EUVIMED